Article Versions Notes

Mahalingam D, Goel S, Aparo S, Patel Arora S, Noronha N, Tran H, Chakrabarty R, Selvaggi G, Gutierrez A, Coffey M, et al. A Phase II Study of Pelareorep (REOLYSIN^®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma. Cancers. 2018; 10(6):160. https://doi.org/10.3390/cancers10060160

Mahalingam, Devalingam, Sanjay Goel, Santiago Aparo, Sukeshi Patel Arora, Nicole Noronha, Hue Tran, Romit Chakrabarty, Giovanni Selvaggi, Andres Gutierrez, Matthew Coffey, and et al. 2018. "A Phase II Study of Pelareorep (REOLYSIN^®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma" Cancers 10, no. 6: 160. https://doi.org/10.3390/cancers10060160

Mahalingam, D., Goel, S., Aparo, S., Patel Arora, S., Noronha, N., Tran, H., Chakrabarty, R., Selvaggi, G., Gutierrez, A., Coffey, M., Nawrocki, S. T., Nuovo, G., & Mita, M. M. (2018). A Phase II Study of Pelareorep (REOLYSIN^®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma. Cancers, 10(6), 160. https://doi.org/10.3390/cancers10060160